Pharmaceutical Industry Cites Challenges in Collecting Quality Metrics Data from CMOs
This article was originally published in The Gold Sheet
The pharmaceutical industry is grappling with some logistical challenges in devising ways to collect quality metrics from CMOs under FDA’s proposed quality metrics program. Some industry members question the feasibility of collecting this information while others say that it is possible, but involves much upfront work and planning.
Register for our free email digests: